Recruiting Hidradenitis Suppurativa Studies in Fountain Valley
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib....
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa....
About Hidradenitis Suppurativa Clinical Trials in Fountain Valley
Hidradenitis suppurativa is a chronic skin condition causing painful lumps under the skin, typically in areas where skin rubs together. It can lead to tunnels under the skin and scarring. Treatment includes antibiotics, biologics, and surgical interventions.
There are currently 2 hidradenitis suppurativa clinical trials recruiting participants in Fountain Valley, CA. These studies are seeking a combined 1,050 participants. Research is being sponsored by Incyte Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hidradenitis Suppurativa Clinical Trials in Fountain Valley — FAQ
Are there hidradenitis suppurativa clinical trials in Fountain Valley?
Yes, there are 2 hidradenitis suppurativa clinical trials currently recruiting in Fountain Valley, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fountain Valley?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fountain Valley research site will contact you about next steps.
Are clinical trials in Fountain Valley free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fountain Valley studies also compensate for your time and travel.
What hidradenitis suppurativa treatments are being tested?
The 2 active trials in Fountain Valley are testing new therapies including novel drugs, biologics, and treatment approaches for hidradenitis suppurativa.
Data updated March 2, 2026 from ClinicalTrials.gov